Neoplastic meningitis screening: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
|||
| Line 19: | Line 19: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Revision as of 02:58, 27 November 2017
|
Neoplastic meningitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neoplastic meningitis screening On the Web |
|
American Roentgen Ray Society Images of Neoplastic meningitis screening |
|
Risk calculators and risk factors for Neoplastic meningitis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
There is insufficient evidence to recommend routine screening for neoplastic meningitis.[1]
Screening
There is insufficient evidence to recommend routine screening for neoplastic meningitis.[1]
References
- ↑ 1.0 1.1 Early detection, diagnosis, and staging of brain tumors. American cancer society. http://www.cancer.org/cancer/braincnstumorsinadults/detailedguide/brain-and-spinal-cord-tumors-in-adults-detection